Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
989
datasets available to search
ShareScore release 0.9.0
Dataset results
989 results for “myelodysplastic syndrome”
Phase II Study to Evaluate Overall Response in Patients With Higher Risk Myelodysplastic Syndromes (MDS) Treated With Azacitidine With or Without Deferasirox.
ClinicalTrials.gov study NCT02159040. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sorafenib in Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00510289. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of NeoRecormon (Epoetin Beta), CellCept (Mycophenolate Mofetil) and Prednisone in Patients With Low or Intermediate Myelodysplastic Syndromes.
ClinicalTrials.gov study NCT00551291. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tipifarnib in Subjects With Myelodysplastic Syndromes
ClinicalTrials.gov study NCT02779777. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Fludarabine and Cytarabine in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01019317. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Decitabine and Vorinostat Conditioning Followed by CD3-/CD19- NK Cells Infusion for High Risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT01593670. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Long Term Safety Study of SyB C-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS) - Extension Study
ClinicalTrials.gov study NCT02002936. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Deferasirox in Treating Patients With Very Low, Low, or Intermediate-Risk Red Blood Cell Transfusion Dependent Anemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT02943668. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Lenalidomide in Combination With Cyclosporine A in Patients With Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00840827. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT02044796. IPD Sharing: Not stated. Countries: 1. Publications: 0.
LBH589 Alone or in Combination With Erythropoietin Stimulating Agents (ESA) in Patients With Low or Int-1 Risk Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT01034657. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Darbepoetin Alfa in Anemic Subjects With Low Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00095264. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Revlimid in Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00360672. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide and Darbepoetin in Low-Intermediate Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01222195. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Omacetaxine in Patients With Intermediate-1 and Higher Risk Myelodysplastic Syndrome (MDS) Post Hypomethylating Agent (HMA) Failure
ClinicalTrials.gov study NCT02159872. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell T
ClinicalTrials.gov study NCT04339101. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00806598. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Oral Clofarabine Study in Patients With Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00299156. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Clinical Activity, Pharmacokinetics (PK) and Pharmacodynamics Study of GSK2879552, Alone or With Azacitidine, in Subjects With High Risk Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT02929498. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Safety and Efficacy of Azacitidine, and Thalidomide in Higher Risk MDS (Myelodysplastic Syndrome)
ClinicalTrials.gov study NCT00704704. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.